Suppr超能文献

转录因子 PlagL2 激活造血祖细胞和白血病细胞中的 Mpl 转录和信号转导。

The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells.

机构信息

Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.

出版信息

Leukemia. 2011 Apr;25(4):655-62. doi: 10.1038/leu.2010.301. Epub 2011 Jan 25.

Abstract

Cytokine signaling pathways are frequent targets of oncogenic mutations in acute myeloid leukemia (AML), promoting proliferation and survival. We have previously shown that the transcription factor PLAGL2 promotes proliferation and cooperates with the leukemia fusion protein Cbfβ-SMMHC in AML development. Here, we show that PLAGL2 upregulates expression of the thrombopoietin receptor Mpl, using two consensus sites in its proximal promoter. We also show that Mpl overexpression efficiently cooperates with Cbfβ-SMMHC in development of leukemia in mice. Finally, we demonstrate that PlagL2-expressing leukemic cells show hyper-activation of Jak2 and downstream STAT5, Akt and Erk1/2 pathways in response to Thpo ligand. These results show that PlagL2 expression activates expression of Mpl in hematopoietic progenitors, and that upregulation of wild-type Mpl provides an oncogenic signal in cooperation with CBFβ-SMMHC in mice.

摘要

细胞因子信号通路是急性髓系白血病(AML)中致癌突变的常见靶点,促进增殖和存活。我们之前已经表明,转录因子 PLAGL2 促进增殖,并与 AML 发育中的白血病融合蛋白 Cbfβ-SMMHC 合作。在这里,我们表明 PLAGL2 通过其近端启动子中的两个共识位点上调血小板生成素受体 Mpl 的表达。我们还表明,Mpl 的过表达可有效地与 Cbfβ-SMMHC 合作,在小鼠中发展白血病。最后,我们证明表达 PlagL2 的白血病细胞在响应 Thpo 配体时显示 Jak2 和下游 STAT5、Akt 和 Erk1/2 途径的过度激活。这些结果表明 PlagL2 表达在造血祖细胞中激活 Mpl 的表达,并且野生型 Mpl 的上调在与 CBFβ-SMMHC 在小鼠中的合作中提供致癌信号。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305b/3076538/e42a68b30fbe/nihms-245943-f0001.jpg

相似文献

2
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
Blood. 2012 Jul 26;120(4):868-79. doi: 10.1182/blood-2012-03-414649. Epub 2012 May 21.
3
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO.
Blood. 2012 Jul 26;120(4):709-19. doi: 10.1182/blood-2012-01-403212. Epub 2012 Feb 14.
4
Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.
Blood. 2005 Apr 1;105(7):2900-7. doi: 10.1182/blood-2004-09-3630. Epub 2004 Dec 7.
6
7
Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal.
Blood. 2014 Mar 13;123(11):1729-38. doi: 10.1182/blood-2013-03-489575. Epub 2014 Jan 21.
8
A novel MPL point mutation resulting in thrombopoietin-independent activation.
Leukemia. 2002 Aug;16(8):1500-6. doi: 10.1038/sj.leu.2402554.
9
Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.
Blood. 2014 Dec 4;124(24):3587-96. doi: 10.1182/blood-2013-12-546275. Epub 2014 Oct 8.

引用本文的文献

1
Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells.
Proc Natl Acad Sci U S A. 2024 Jul 30;121(31):e2404193121. doi: 10.1073/pnas.2404193121. Epub 2024 Jul 23.
2
PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling.
Cell Death Dis. 2023 Jul 15;14(7):433. doi: 10.1038/s41419-023-05970-2.
3
The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer.
Am J Physiol Gastrointest Liver Physiol. 2023 Aug 1;325(2):G196-G211. doi: 10.1152/ajpgi.00058.2022. Epub 2023 Jun 13.
4
PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
BMC Gastroenterol. 2023 Jan 4;23(1):2. doi: 10.1186/s12876-022-02609-y.
7
Ubiquitin-specific peptidase 37: an important cog in the oncogenic machinery of cancerous cells.
J Exp Clin Cancer Res. 2021 Nov 10;40(1):356. doi: 10.1186/s13046-021-02163-7.
9
PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1.
Theranostics. 2021 Jan 1;11(2):700-714. doi: 10.7150/thno.47800. eCollection 2021.

本文引用的文献

2
miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
Blood. 2009 Oct 8;114(15):3255-64. doi: 10.1182/blood-2009-06-229898. Epub 2009 Aug 19.
3
Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.
Mol Cell Biol. 2009 Aug;29(15):4103-15. doi: 10.1128/MCB.00090-09. Epub 2009 May 26.
5
Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche.
Cell Stem Cell. 2007 Dec 13;1(6):685-97. doi: 10.1016/j.stem.2007.10.020. Epub 2007 Nov 20.
6
LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.
J Cell Physiol. 2007 Jan;210(1):16-25. doi: 10.1002/jcp.20835.
7
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.
Blood. 2006 Nov 15;108(10):3472-6. doi: 10.1182/blood-2006-04-018879. Epub 2006 Jul 25.
8
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
PLoS Med. 2006 Jul;3(7):e270. doi: 10.1371/journal.pmed.0030270.
9
Lineage-specific hematopoietic growth factors.
N Engl J Med. 2006 May 11;354(19):2034-45. doi: 10.1056/NEJMra052706.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验